Association of LH/FSH Ratio with Thyroid Stimulating Hormone and Prolactin Levels in Women with Polycystic Ovarian Syndrome in Pakistan

Authors

  • Sagheera Anjum Munaver Department of Obstetrics and Gynecology, Fazaia Ruth Pfau Medical College Karachi, Pakistan.
  • Fatima Zahra Department of Medicine, Fazaia Ruth Pfau Medical College Karachi, Pakistan.
  • Farzana Azhar Department of Obstetrics and Gynecology, Liaquat College of Medicine and Dentistry Karachi, Pakistan.
  • Quratul Aman Siddiqui Department of Obstetrics and Gynecology, Liaquat National Hospital & Medical College Karachi, Pakistan.

DOI:

https://doi.org/10.36570/jduhs.2023.1.1636

Keywords:

PCOS, LH/FSH ratio, TSH, Prolactin

Abstract

Objective: The aim of our study is to find the association of Luteinizing Hormone/Follicle Stimulating Hormone ratio (LH/FSH ratio) with Thyroid Stimulating Hormone (TSH) and prolactin levels in women with Polycystic Ovarian Syndrome (PCOS).
Methods: An observational cross-sectional study was conducted in the gynecology and endocrine outpatient departments of Darul Sehat hospital from March to December 2019. The demographic data were noted, and lab investigations were done on 2nd and 3rd day of menstrual cycle. All cases were divided into 2 groups, one with LH/FSH ratio ≤2 and other >2. All females of reproductive age 15-44 years who were diagnosed with PCOS according to Rotterdam criteria were included.
Results: Of 130 women, the mean age was 26.16 ± 5.81 years. There were 103 (79.2%) women found with LH/FSH ≤ 2 and 27 (20.8%) with LH/FSH > 2. Mean difference of TSH was found significantly higher in PCOS women with LH/FSH > 2 as compared to LH/FSH ≤ 2 i.e., 3.74 ± 6.49 vs. 2.32 ± 1.54 respectively (p-value 0.049). While an insignificant mean difference of PCOS with LH/FSH was found with prolactin (p-value 0.536) and insulin (p-value 0.902). A significantly weak positive correlation of prolactin was found with LH/FSH ratio (r: 0.191, p-value 0.029).
Conclusion: A significant correlation was found between LH/FSH ratio and TSH levels in women with PCOS which justifies the need for further evaluation. Therefore, thyroid function should be assessed in women with PCOS with raised LH/FSH ratio which would help in management.

Downloads

Download data is not yet available.

References

Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev 2016; 37:467-520. doi:10.1210/er.2015-1104

Sanchez-Garrido MA, Tena - Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Metab 2020; 35:100937. doi:10.1016/j.molmet.2020.01.001

Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011; 7:219-31. doi:10.1038/nrendo.2010.217

Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 2014; 171:P1-P29. doi:10.1530/EJE-14-0253

McKenna TJ. Pathogenesis and treatment of polycystic ovary syndrome. N Engl J Med 1988 ;318:558-62. doi:10.1056/NEJM198803033180906

Richard SL RA. Androgen excess disorders. Danforth's Obstetrics and Gynecology, 8th edition, Lippincott Williams & Wilkins, Philadlphia 2003; Chapter 37:66372.

Johansson J, Stener-Victorin E. Polycystic ovary syndrome: effect and mechanisms of acupuncture for ovulation induction. Evid Based Complement Alternat Med 2013; 2013:762615. doi:10.1155/2013/762615

Ruman U, Chowdhury TA, Chowdhury TS, Mahmud N, Hasan I. TSH & prolactin versus LH & FSH: a dialemma in hormone assay for patients with primary or secondary infertility in a tertiary care hospital in Bangladesh. Obstet Gynecol Int J 2015; 2:212-4. doi:10.15406/ogij.2015.02.00064

Karasek M, Pawlikowski M, Lewinski A. Hyperprolact-inemia: causes, diagnosis, and treatment. Endokryn-ologia Polska 2006; 57:656-62.

Davoudi Z, Araghi F, Vahedi M, Mokhtari N, Gheisari M. Prolactin Level in Polycystic Ovary Syndrome (PCOS): An approach to the diagnosis and management. Acta Biomed 2021; 92:e2021291. doi:10.23750/abm.v92i5.9866

Ding X, Yang L, Wang J, Tang R, Chen Q, Pan J, et al. Subclinical Hypothyroidism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2018; 9:700. doi:10.3389/fendo.2018.00700

Fatima M, Amjad S, Sharaf Ali H Sr, Ahmed T, Khan S, Raza M, et al. Correlation of Subclinical Hypothyroidism With Polycystic Ovary Syndrome (PCOS). Cureus 2020; 12:e8142. doi:10.7759/cureus.8142

Neven AC, Laven J, Teede HJ, Boyle JA. A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. In Seminars in reproductive medicine. Thieme Medical Publishers 2018; 36 pp.005-012.

Catteau-Jonard S, Dewailly D. Pathophysiology of polycystic ovary syndrome: the role of hyperandrog-enism. Front Horm Res 2013; 40:22–7.

PCOS UK. The polycystic ovary syndrome: guidance for diagnosis and management.Available at https://www.guidelines.co.uk/womens-health/pcos-uk-guideline/236071.article Accssed June 2020.

Jesmin ZF, Saha E, Yasmin F, Ara A, Khaliduzmnan SM. Diagonostic parameters of polycystic ovarian syndrome in outpatient setting. Bang Med J Khulna 2020; 53:17-22.

Nath CK, Barman B, Das A, Rajkhowa P, Baruah P, Bar-uah M, et al. Prolactin and thyroid stimulating hormone affecting the pattern of LH/FSH secretion in patients with polycystic ovary syndrome: A hospital-based study from North East India. J Family Med Prim Care 2019; 8:256.

Banaszewska B, Spaczynski RZ, Pelesz M, Pawelczyk L. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia. Rocz Akad Med Bialymst 2003; 48:131-4.

Park YJ, Shin H, Jeon S, Cho I, Kim YJ. Menstrual Cycle Patterns and the Prevalence of Premenstrual Syndrome and Polycystic Ovary Syndrome in Korean Young Adult Women. Healthcare (Basel) 2021; 9:56. doi:10.3390/healthcare9010056

Memon T F , Channar M, Shah SAW, Shaikh A, Batool M, Shri N . Polycystic ovary syndrome: risk factors and associated features among university students in Pakistan. JPUMHS 2020; 10. 22-9.

Sidra S, Tariq MH, Farrukh MJ, Mohsin M. Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. PLoS One 2019; 14:e0223329. doi:10.1371/journal.pone.0223329

Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Mu-rad MH, Pasquali R, et al. Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98:4565-92. doi:10.1210/jc.2013-2350

Cena H, Chiovato L, Nappi RE. Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists. J Clin Endocrinol Metab 2020; 105:e2695–709. doi:10.1210/clinem/dgaa285

Alnakash AH, Al-Tae e NK. Polycystic ovarian syndrome: the correlation between the LH/FSH ratio and disease manifestations. Middle East Fertil Soc J 2007;12:35.

Mitrasinovic - Brulic M, Buljan M, Suljevic D, Brulic M, Bulgan M. Sulgevic D. Association of LH/FSH ratio with menstrual cycle regularity and clinical features of patients with polycystic ovary syndrome. Middle East Fertil Soc J 2021; 40: 2-9. doi.org/10.1186/s43043-021-00085-0

Enzevaei A, Salehpour S, Tohidi M, Saharkhiz N. Subcli-nical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship? Iran J Reprod Med 2014; 12:481-6.

Kamrul-Hasan A, Aalpona FT, Selim S. Impact of Subclinical Hypothyroidism on Reproductive and Metabolic Parameters in Polycystic Ovary Syndrome - A Crosssectional Study from Bangladesh. Eur Endocrinol 2020; 16:156-60. doi:10.17925/EE.2020.16.2.156

Davoudi Z, Araghi F, Vahedi M, Mokhtari N, Gheisari M. Prolactin level in polycystic ovary syndrome (PCOS): An approach to the diagnosis and management. Acta Biomed 2021; 92:e2021291. doi:10.23750/abm.v92i5.9866

Robin G, Catteau-Jonard S, Young J, Dewailly D. Lien physiopathologique entre syndrome des ovairespoly-microkystiqueset hyperprolactinemie: mytheour-ealite? [Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality?]. Gynecol Obstet Fertil (French) 2011; 39:141-5. doi:10.1016/j.gyobfe.2010.11.002.

Downloads

Published

2022-10-19

How to Cite

Munaver, S. A., Zahra, F., Azhar, F., & Siddiqui, Q. A. (2022). Association of LH/FSH Ratio with Thyroid Stimulating Hormone and Prolactin Levels in Women with Polycystic Ovarian Syndrome in Pakistan. Journal of the Dow University of Health Sciences (JDUHS), 17(1), 25–30. https://doi.org/10.36570/jduhs.2023.1.1636

Issue

Vol. 17 No. 1

Section

Original Articles

License

Copyright (c) 2022 Sagheera , Fatima Zahra, Farzana Azhar, Quratul Aman Siddiqui

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Articles published in the Journal of Dow University of Health Sciences are distributed under the terms of the Creative Commons Attribution Non-Commercial License https://creativecommons.org/ licenses/by-nc/4.0/. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal.